132 related articles for article (PubMed ID: 22351303)
1. Focused rescreening of NILM Pap slides from women ≥ 30 years of age with positive high risk HPV DNA: an enhanced quality control measure.
Sturgis CD; Schaaf MR; Tickman RJ
Diagn Cytopathol; 2013 May; 41(5):399-403. PubMed ID: 22351303
[TBL] [Abstract][Full Text] [Related]
2. NILM Pap slides from women 30 years of age and older with positive high-risk HPV DNA. Focused rescreening prior to report issuance, an enhanced quality control measure.
Cormier K; Schaaf M; Hamilton S; Tickman RJ; Perez-Reyes N; Sturgis CD
Am J Clin Pathol; 2014 Apr; 141(4):494-500. PubMed ID: 24619749
[TBL] [Abstract][Full Text] [Related]
3. Implementation of the ThinPrep Imaging System in a tertiary military medical center.
Duby JM; DiFurio MJ
Cancer; 2009 Aug; 117(4):264-70. PubMed ID: 19536887
[TBL] [Abstract][Full Text] [Related]
4. [HPV E6 and E7 mRNA combined with HPV 16 and 18 or 45 genotyping testing as a means of cervical cancer opportunistic screening].
Wang JJ; Dong J; Deng ZX; Wang PF; Zhang XX; Du Y
Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):301-306. PubMed ID: 31154710
[No Abstract] [Full Text] [Related]
5. Negative computer-imaged ThinPrep Pap test and positive hybrid capture2 HPV co-testing results: A quality assurance review.
Rao R; Molina D; Halligan AM; Vakil B; Alperstein SA; Hoda RS
Diagn Cytopathol; 2015 Sep; 43(9):763-9. PubMed ID: 26173579
[TBL] [Abstract][Full Text] [Related]
6. Performance of HPV DNA testing with hybrid capture 2 in triaging women with minor cervical cytologic abnormalities (ASC-US/LSIL) in Northern Thailand.
Khunamornpong S; Settakorn J; Sukpan K; Srisomboon J; Suprasert P; Siriaunkgul S
Asian Pac J Cancer Prev; 2014; 15(24):10961-6. PubMed ID: 25605209
[TBL] [Abstract][Full Text] [Related]
7. Immediate histopathologic follow-up of cervista and aptima high-risk HPV assays in women with LSIL cytology.
Zhang H; Varma KR; Han M; Matsko J; Zhao C
Cancer Cytopathol; 2018 Aug; 126(8):525-532. PubMed ID: 29797678
[TBL] [Abstract][Full Text] [Related]
8. Correlation of histopathologic/cytologic follow-up findings with vaginal ASC-US and ASC-H Papanicolaou test and HPV test results.
Bansal M; Li Z; Zhao C
Am J Clin Pathol; 2012 Mar; 137(3):437-43. PubMed ID: 22338056
[TBL] [Abstract][Full Text] [Related]
9. CITRUS, cervical cancer screening trial by randomization of HPV testing intervention for upcoming screening: Design, methods and baseline data of 18,471 women.
Morisada T; Teramoto K; Takano H; Sakamoto I; Nishio H; Iwata T; Hashi A; Katoh R; Okamoto A; Sasaki H; Nakatani E; Teramukai S; Aoki D
Cancer Epidemiol; 2017 Oct; 50(Pt A):60-67. PubMed ID: 28818742
[TBL] [Abstract][Full Text] [Related]
10. Rescreening of high-risk HPV positive Papanicolaou tests initially screened as negative is a low yield procedure in the era of HPV genotyping.
Narkcham S; Mody DR; Jones A; Thrall MJ
J Am Soc Cytopathol; 2021; 10(6):558-564. PubMed ID: 34103275
[TBL] [Abstract][Full Text] [Related]
11. Knowledge of the HPV status biases cytotechnologists' interpretation of Pap tests originally diagnosed as negative for intraepithelial lesion or malignancy.
Doxtader EE; Brainard JA; Underwood D; Chute DJ
Cancer Cytopathol; 2017 Jan; 125(1):60-69. PubMed ID: 27731938
[TBL] [Abstract][Full Text] [Related]
12. A Multi-Institutional Feasibility Study on the Use of Automated Screening Systems for Quality Control Rescreening of Cervical Cytology.
Sugiyama Y; Sasaki H; Komatsu K; Yabushita R; Oda M; Yanoh K; Ueda M; Itamochi H; Okugawa K; Fujita H; Tase T; Nakatani E; Moriya T
Acta Cytol; 2016; 60(5):451-457. PubMed ID: 27673689
[TBL] [Abstract][Full Text] [Related]
13. Human Papillomavirus Genotyping among Different Cervical Smears in Duhok/Iraq.
Pity IS; Abdo HM; Goreal AA
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2059-2064. PubMed ID: 31350966
[TBL] [Abstract][Full Text] [Related]
14. Prospective and retrospective review of gynecologic cytopathology: findings from the College of American Pathologists Gynecologic Cytopathology Quality Consensus Conference working group 2.
Brainard JA; Birdsong GG; Elsheikh TM; Hartley DA; Naik K; Neal MH; Souers RJ; Henry MR
Arch Pathol Lab Med; 2013 Feb; 137(2):175-82. PubMed ID: 23368859
[TBL] [Abstract][Full Text] [Related]
15. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
[TBL] [Abstract][Full Text] [Related]
16. Atypical squamous cells of undetermined significance in liquid-based cytologic specimens: results of reflex human papillomavirus testing and histologic follow-up in routine practice with comparison of interpretive and probabilistic reporting methods.
Levi AW; Kelly DP; Rosenthal DL; Ronnett BM
Cancer; 2003 Aug; 99(4):191-7. PubMed ID: 12925979
[TBL] [Abstract][Full Text] [Related]
17. The AutoPap 300 QC System multicenter clinical trials for use in quality control rescreening of cervical smears: I. A prospective intended use study.
Patten SF; Lee JS; Wilbur DC; Bonfiglio TA; Colgan TJ; Richart RM; Cramer H; Moinuddin S
Cancer; 1997 Dec; 81(6):337-42. PubMed ID: 9438458
[TBL] [Abstract][Full Text] [Related]
18. Off-label high-risk HPV DNA testing of vaginal ASC-US and LSIL cytologic abnormalities at Parkland hospital.
Chappell CA; West AM; Kabbani W; Werner CL
J Low Genit Tract Dis; 2010 Oct; 14(4):352-5. PubMed ID: 20885164
[TBL] [Abstract][Full Text] [Related]
19. [Use of high-risk human papillomavirus DNA testing to deal with atypical squamous cells undetermined significance and low squamous intraepithelial lesion].
Guo YL; You K; Geng L; Zhang XW; Shen XY; Yao YJ; Fan XH
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):480-2. PubMed ID: 17068618
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs.
Zhao D; Zhang L; Xie F; Peng D; Wei J; Jiang L; Zhang S; Qi D
BMC Cancer; 2020 Aug; 20(1):810. PubMed ID: 32847541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]